Aetna Inc. Plans Quarterly Dividend of $0.25 (AET)
Aetna Inc. (NYSE:AET) declared a quarterly dividend on Friday, September 30th. Investors of record on Thursday, October 13th will be paid a dividend of 0.25 per share on Friday, October 28th. This represents a $1.00 annualized dividend and a yield of 0.87%.
Aetna (NYSE:AET) opened at 115.45 on Monday. The company has a market capitalization of $40.50 billion, a PE ratio of 16.92 and a beta of 0.62. Aetna has a 52 week low of $92.42 and a 52 week high of $123.57. The company’s 50-day moving average price is $116.86 and its 200 day moving average price is $115.71.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $2.21 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.12 by $0.09. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The business had revenue of $15.95 billion for the quarter, compared to the consensus estimate of $15.69 billion. During the same period last year, the business earned $2.05 EPS. The firm’s revenue was up 4.7% compared to the same quarter last year. On average, equities research analysts anticipate that Aetna will post $8.05 EPS for the current year.
A number of research analysts recently weighed in on AET shares. Morgan Stanley reissued a “buy” rating on shares of Aetna in a research note on Tuesday, June 14th. Sanford C. Bernstein started coverage on Aetna in a research note on Thursday, June 16th. They issued an “outperform” rating and a $142.00 price objective on the stock. Leerink Swann reissued an “outperform” rating on shares of Aetna in a research note on Tuesday, June 21st. Wolfe Research assumed coverage on Aetna in a research report on Tuesday, June 28th. They issued an “outperform” rating and a $154.00 price target on the stock. Finally, Credit Suisse Group AG reaffirmed a “hold” rating and issued a $120.00 price target on shares of Aetna in a research report on Wednesday, June 29th. Seven research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Aetna currently has an average rating of “Buy” and an average price target of $132.79.
In related news, Director Jeffrey E. Garten sold 7,100 shares of the business’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Shawn M. Guertin sold 45,328 shares of the business’s stock in a transaction on Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total value of $5,448,878.88. Following the completion of the sale, the insider now directly owns 44,883 shares in the company, valued at approximately $5,395,385.43. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in the stock. Capital International Investors raised its stake in shares of Aetna by 7.5% in the second quarter. Capital International Investors now owns 4,650,500 shares of the company’s stock valued at $567,966,000 after buying an additional 324,000 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Aetna by 6.9% in the second quarter. Franklin Resources Inc. now owns 1,016,120 shares of the company’s stock valued at $124,099,000 after buying an additional 65,911 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its stake in shares of Aetna by 10.2% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 949,612 shares of the company’s stock valued at $115,976,000 after buying an additional 88,010 shares in the last quarter. Bessemer Group Inc. raised its stake in shares of Aetna by 1.2% in the second quarter. Bessemer Group Inc. now owns 948,697 shares of the company’s stock valued at $115,864,000 after buying an additional 11,256 shares in the last quarter. Finally, Capital Guardian Trust Co. raised its stake in shares of Aetna by 1.6% in the second quarter. Capital Guardian Trust Co. now owns 653,333 shares of the company’s stock valued at $79,792,000 after buying an additional 10,364 shares in the last quarter. 91.95% of the stock is currently owned by institutional investors and hedge funds.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.